The data analysis period was February 27, 2015 through July 31, 2018, for a total of 41 months. After completing the online screening, 515 plan members were eligible to participate in the digital care portion of the program. For analysis purposes, eligible participants were split into two groups: the Kiio group (those who engaged with the program for long enough to advance beyond level one), and the reference group (those who did not engage long enough to progress past level one or who did not engage at all). Results clearly demonstrate the added value of the Kiio program on medical spend and utilization of urgent care and more aggressive diagnostics and treatments.*
Low-back-pain-related medical spend decreased 53% in the Kiio group, not including pharmacy. There was no use of ED and Urgent Care in the Kiio group post-enrollment; in the reference group, ED/Urgent Care claims increased 47%. And the Kiio group was 1.7 times less likely to have an MRI and 1.8 times less likely to have a spinal injection as compared to the reference group.
*p<0.01-0.05